SCHEMBL13992479

SCHEMBL13992479

CCCc1cc(C)c(OCC(=O)NCCN(C)C)c(CC)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.50
▸ CYP1A2 P05177 2/20 0.50
▸ CYP2D6 P10635 2/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ LGALS1 P09382 1/20 0.49
▸ TSHR P16473 1/20 0.45
▸ KDM4E B2RXH2 1/20 0.42
▸ GAA P10253 1/20 0.40
▸ HTT P42858 3/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CASP2 P42575 1/20 0.39
▸ LMNA P02545 2/20 0.38
▸ BCHE P06276 1/20 0.37
▸ ACHE P22303 1/20 0.37
▸ DNM1 Q05193 1/20 0.37
▸ ROCK2 O75116 1/20 0.37
▸ ROCK1 Q13464 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16501713 0.90 NPSR1 (0.49) NPSR1ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL13992478 0.89 NPSR1 (0.44) NPSR1ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL10046768 0.86 NPSR1 (0.49) NPSR1ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL15698374 0.85 BCHE (0.43) NPSR1ALDH1A1TSHRGAAHTT
SCHEMBL13992481 0.82 NPSR1 (0.52) NPSR1ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL14213209 0.82 CYP1A2 (0.57) NPSR1ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL16501714 0.81 NPSR1 (0.50) NPSR1ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL10046737 0.78 THRA (0.42) NPSR1ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL13992476 0.78 LGALS1 (0.63) NPSR1ALDH1A1CYP1A2CYP2D6CYP2C19
SCHEMBL13992477 0.77 NPSR1 (0.40) NPSR1ALDH1A1CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080300164-A1 Calixarene-Based Peptide Conformation Mimetics, Methods of Use, and Methods of Making REGENTS OF THE UNIVERSITY OF MINNESOTA (US) 2008-12-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080300164-A1 Calixarene-Based Peptide Conformation Mimetics, Methods of Use, and Methods of Making CLSPN, BID, CALU NPSR1 1564/4885ALDH1A1 4794/4885CYP1A2 4390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback